Fabry Disease Treatment Market size is expected to value USD 2.4 billion in 2024 and reach a market value of USD 4.9 billion in 2033 at a CAGR of 8.3%. Fabry disease is a rare genetic disorder caused by mutations in the GLA gene, which leads to a deficiency in the enzyme alpha-galactosidase A. Symptoms of this disease involve pain in the hands and feet, clusters of dark red spots on t... https://dimensionmarketresearch.com/report/fabry-disease-treatment-market/